Upcoming Events | Related News

Upcoming Events

You may find that the following meetings will have presentations of interest to you. International congresses and meetings where you will find papers, abstracts and posters relating to new and exciting technologies.

This listing of meetings is provided as an educational service to the medical community. Bioheart, Inc. has no control over the content/type of information presented at these meetings. Dates are subject to change by the conference organizers.

Meeting

Location

Dates

The CCIB - Forum Convention Centre
Rambla Prim, 1-17
08109 Barcelona, Spain
May 13 - 16, 2008

Heart Failure 2008

The Heart Failure Congress, the annual meeting of the Heart Failure Association of the ESC, is dedicated to all professionals interested in the broad spectrum of problems relating to heart failure.

Congress Centre
Milano Convention Centre
Via Gattamelata 5
Milan, Italy

Tel: +39 02 4997.7134
Fax: +39 02 4801.0265

June 14-17, 2008

14th World Congress on Heart Disease

International Academy of Cardiology
Annual Scientific Sessions 2008

The Fairmont Royal York
100 Front Street West
Toronto, Ontario, Canada
July 26-29, 2008
Metro Toronto Convention Centre
Toronto, Ontario, Canada
September 21-24, 2008

TCT 2008

Washington Convention Center · Washington, DC
October 12-17, 2008

Scientific Sessions 2008
[American Heart Association]

Ernest N. Morial Convention Center
900 Convention Center Blvd.
New Orleans, LA
November 8-12, 2008

Cell Therapy for Cardiovascular Disease

Tysons Corner Ritz Carlton
Washington, DC
November 20-21, 2008
 

TOP


Related News

May, 2008

Cell Therapy in the Cath Lab for Heart Failure: A look at MyoCell® Therapy and the SEISMIC Trial

Cath Lab Digest talks with Warren Sherman, MD, Director, Cardiac Cell-based Endovascular Therapies, Columbia University Medical Center, New York, New York and Principal Investigator of the Phase II/III MARVEL Study.
View this Article... Adobe PDF File [Requires Adobe Acrobat Browser Plugin]

   
   
April 1, 2008

Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
View Press Release... Adobe PDF File [Requires Adobe Acrobat Browser Plugin]

   
February 21, 2008

New Victories for Adult Stem Cell Research
The Adult Stem Cell Research Network announced that new clinical and pre-clinical data on adult stem cells was presented at the 4th Annual Meeting of Cell Therapy for Cardiovascular Disease Sponsored by the Cardiovascular Research Foundation. Dr. Warren Sherman of Columbia University presented final one year results of the MYOHEART trial sponsored by Bioheart, Inc., in which 83 percent of patients treated in this manner with adult muscle stem cells, also known as myoblasts, improved.
View Press Release... Adobe PDF File [Requires Adobe Acrobat Browser Plugin]

   
February 2, 2008

Bioheart New Joint Venture Facility In Asia
On September 11, 2007, BioHeart Manufacturing (BHM) inaugurated its cGMP certified cell culture facility in Seoul, South Korea. This is South Korea’s first such facility. Built at an investment of $22 million the BHM facility is a joint venture between Seoul-headquartered BHK Inc and US-based BioHeart Inc. Bioheart has the capacity to culture 46,000 cases annually in this building.
View Facility Photo's Adobe PDF File [Requires Adobe Acrobat Browser Plugin]

   
November 21, 2007

Regulatory Panel at Angiomyogenesis Symposium at CRT 2008
Regulatory Panel Session will take place on Tuesday evening of the Symposium on February 12, 2008.
View Event Brochure | Register Online Adobe PDF File [Requires Adobe Acrobat Browser Plugin]

   
March 7, 2007

Bioheart, Inc. Appoints William H. Pinon President and CEO
Cardiovascular Industry Veteran Brings Nearly 20 Years of Experience to Bioheart
View Press Release

   
February 26, 2007

Bioheart, Inc. Provides Unrestricted Research Grant to the Ohio Cell-Based Therapy Consortium
View Press Release

   
January, 2007

Myocardial Repair By Percutaneous Cell Transplantation Of Autologous Skeletal Myoblasts As A Stand Alone Procedure In Post Myocardial Infarction Chronic Heart Failure Patients.

Patrick W. Serruys, MD, PhD on behalf of the BIOHEART European 005/006 and 008 study investigators. (3rd Annual Conference on Cell Therapy for Cardiovascular Diseases, New York, January, 2007)

View This Info... Adobe PDF File [Requires Adobe Acrobat Browser Plugin]


MYOHEART US Phase I Study - Interim Analysis - January 2007

Download Microsoft PowerPoint SlideShow
(32kb - RIGHT CLICK AND "SAVE TO HARD DRIVE" - Requires: PowerPoint Viewer for Windows | PowerPoint Viewer for MAC)

   
January 17, 2007

Dr. Jorge Genovese Joins Bioheart, Inc. Scientific Advisory Board
View Press Release

   
December 27, 2006

Tissue Genesis Licenses Technology to Florida Company
View Press Release

   
November 17, 2006 Bioheart, Inc. Expands Clinical Trials Of Adult Myogenic Stem Cell Treatment For Heart Attack And Advanced Heart Failure Patients

Bioheart, Inc., a biotechnology company focused on the development of innovative cell therapies designed to repair areas of damaged muscle tissue in a patient's heart and improve cardiac function, is expanding its United States and European clinical trials of its MyoCell(TM) adult myogenic (muscle) stem cell composition and MyoCath(R) needle-injection catheter product candidates. MyoCell(TM) is a non-acute, clinical therapy for treatment of damage to the heart in patients in Class II or Class III heart failure. Bioheart believes that its MyoCell(TM) therapy has the potential to become a leading non-acute treatment for severe damage to the heart due to its perceived ability to satisfy a presently unmet demand for more effective and/or more affordable non-acute therapies for heart damage. Read the Article

   
November 15, 2006

Cell Transfer for Heart Patient

A man who has had six heart attacks is one of the first UK patients to undergo an experimental cell transfer. Read the Full Story... | View BBC News Video

   
November 8 , 2006

Ascent Closes First Deal of $100M Medical Technology Fund.

Recently, Ascent has become the lead investor in a private placement for cutting-edge cardiovascular technology startup, Bioheart, a US based company that is conducting clinical studies in the US and Europe for regulatory approval prior to marketing globally. Bioheart's technology aims to change the way congestive heart failure is treated by using a new method of cell engineering. Bioheart will establish a cell engineering and production facility in the Middle East. Read the Full Article...

   
August 8 , 2006

Bioheart Acquires Exclusive Option Rights to Tissue Genesis' Cell Technology for the Acute Treatment of Heart Attacks.
Read this Article

   
July 31, 2006

U of M Uses Robotic Surgery Techniques in Cell Therapy Research for Cardiac Repair.
Read this Article

   
June 26, 2006

Bioheart, Inc. to Receive Funds From a Grant Awarded by the State of Ohio to Further Develop Adult Stem Cell Therapies.
Read this Article

   
May 19, 2006

Tricardia Inks Licensing Deal With Bioheart.
Read this Article

   
June 2, 2006

Bioheart and PharmaCell Open GMP Lab Facility in Europe to Support Adult Stem Cell Research.

View Press Release

   
April 27, 2006

Bioheart, Inc and Tricardia, LLC Sign Patent Licensing Agreement.

View Press Release

   
March 2006 Intramyocardial Injection Of Skeletal Myoblasts: Long-Term Follow-up with Pressure-Volume Loops. Steendijk P, Smits PC, Valgimigli M, van der Giessen WJ, Onderwater EE, Serruys PW. View an Abstract of this Article | View the Full Article  Adobe PDF File
   
March 24, 2006

Licensing Deal, Funding Boost Bioheart.
View PDF Article [100k - Adobe PDF File [Requires Adobe Acrobat Browser Plugin]

   
 

Bioheart Hires Jason Sholder to Lead a Project of Developing an Implantable Electrical Stimulation Device to Complement Its Cell Transplantation Product Platform.

View Press Release

   
February 20, 2006

Bioheart Licenses Cell Patent.
Read this Article

   
February 20, 2006

Bioheart, Inc. and Cleveland Clinic Sign Major Patent Licensing Agreement.
Read this Article

   
February 20, 2006

Bioheart Licenses Cell Patent - Deal With Cleveland Clinic Focuses On Repairing Heart Tissue.
Read this Article

TOP

Bioheart, Inc. | 13794 NW 4th Street, Suite 212 | Sunrise, Florida 33325
Telephone: (954)-835-1500 | Fax: (954)-845-9976 | email:
bioheart@bioheartinc.com
BPI Web Design Web site by Bromley Printing and Design